The invention provides new processes for preparing polyglutamic acid-therapeutic agent conjugates for clinical development and pharmaceutical use, and polyglutamic acid-therapeutic agent conjugates prepared by these processes.

 
Web www.patentalert.com

< Modulation of glucagon receptor expression

> Polymorphic crystalline forms of tiacumicin B
~ 00447